Webe Honey – Lifestyle
Home
Sample Page
Author:
Ascelia Pharma
Quarterly Report Q1 2026: Orviglance(R) Approaching Transformative Milestones
May 12, 2026
Bulletin from the Annual General Meeting in Ascelia Pharma AB on 4 May 2026
May 4, 2026
Change in Number of Shares and Votes in Ascelia Pharma AB
April 30, 2026
Annual Report 2025: Orviglance NDA submitted to the FDA, PDUFA-date set for July 2026
April 9, 2026
Notice of Annual General Meeting in Ascelia Pharma AB
March 30, 2026
Ascelia Pharma Announces Acceptance of Orviglance Data for Oral Presentation at the Annual Radiology Congress ESGAR 2026
March 27, 2026